| Name | Title | Contact Details |
|---|
Entrust Healthcare is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The combination of Tufts Health Plan and Harvard Pilgrim Health Care represents the coming together of two of New England`s most iconic nonprofit health care companies. Representing nearly 90 years of combined service to our members and the community, together we are building upon our diverse legacies and innovative collaboration by making it our purpose to guide and empower healthier lives for everyone — no matter their age, health, race, identity, or income. That`s why we`ve named our new corporate entity Point32Health. The Point32Health name is inspired by the 32 points on a compass. It speaks to the critical role we play in guiding and empowering the people we serve to achieve healthier lives. Point32Health is our corporate name. Harvard Pilgrim Health Care, Tufts Health Plan and our other brands will continue to show up as they do today—trusted, high-quality health plans for people across the country. As Point32Health, we strive to be a different kind of nonprofit health and well-being company, with a broad range of health plans, and innovative tools that make navigating health and well-being easier, guiding our members at every step of their health care journey to better health outcomes. We are committed to providing high-quality and affordable health care, improving the health and wellness of our members, and creating healthier communities across the country.
Southern Wake Family Medicine is a Fuquay Varina, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Harvest Technologies Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Plymouth, MA. To find more information about Harvest Technologies Corporation, please visit www.harvesttech.com
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT™ Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.